The global “injectable cytotoxic drugs” market size is expected to reach USD 29.60 billion by 2027, exhibiting a CAGR of 8.1% during the forecast period. The rising cases of cancer have resulted in high dependency on cytotoxic drugs, which, in turn, will bolster healthy growth of the market, states Fortune Business Insights, in a report, titled “Injectable Cytotoxic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Alkylating Drugs, Cytotoxic Antibodies, Antimetabolites, Plant Alkaloids, and Others), By Application (Oncology, Rheumatoid Arthritis, Multiple Sclerosis, and Others) By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The market size stood at USD 15.81 billion in 2019.
The report covers:
- Global Injectable Cytotoxic Drugs Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
The coronavirus incident has caused massive loss and disruption to various industries across the globe. We understand that this health disaster has negatively impacted various sectors around the world. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling, and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.
We are making endless efforts to uplift businesses in this crucial need of the hour. Our expertise and experience can offer enormous benefits to help regain this global pandemic.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/injectable-cytotoxic-drugs-market-104705
Leading Players operating in the Injectable Cytotoxic Drugs Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Johnson and Johnson Services Inc., (U.S)
- Sanofi (France)
- Eli Lilly and Company (U.S)
- Bristol-Myers Squibb Company (New York, U.S)
- Hoffmann-La Roche Ltd. (Basel, Switzerland)
- Novartis AG (Basel, Switzerland)
- Pfizer, Inc (New York, U.S)
- Merck & Co. Inc (New Jersey, U.S)
- Amgen (California, U.S.)
Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/injectable-cytotoxic-drugs-market-104705
Rising Number of Cancer Patients to Amplify Growth in North America
The market in North America stood at USD 7.69 billion in 2019 and is expected to remain dominant during the forecast period. The growth is attributable to the rising number of cancer patients. Moreover, the increasing adoption of injectable cytotoxic drugs will support the development of the market. For Instance, according to the American Cancer Society, in 2019, an estimated 268,600 new cases of invasive breast cancer were diagnosed in women, and about 2,670 cases were diagnosed in men in the U.S alone. The Asia Pacific market is expected to expand radically during the forecast period due to the increasing patient pool and expanding healthcare spending in the region.
Rising Prevalence of Cancer and Rheumatoid Arthritis to Drive Market
The increasing incidence of cancer due to various environmental factors such as tobacco smoking, urbanization, and changing diet patterns will spur growth opportunities for the market. According to the World Health Organization (WHO), cancer is a growing burden, and the number of new cancer cases are expected to rise from 18.1 million in 2018 to 29.4 million by 2040. Moreover, the rising prevalence of rheumatoid arthritis and multiple sclerosis will have a tremendous impact on the market in the forthcoming years. The growing awareness about the benefits of injectable cytotoxic drugs in cancer treatment can encourage the market’s healthy growth. According to the Center for Disease Control and Prevention, around 41 individuals out of 100,000 are affected with rheumatoid arthritis each year in the U.S.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/injectable-cytotoxic-drugs-market-104705
Detailed Table of Content:
- Introduction
- Market Scope
- Market Segmentation
- Market Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Key Cancer Indications –Key Regions/Country
- Regulatory Scenario – Key Countries/Regions
- Pipeline Analysis
- Impact of COVID-19 on the Global Market
- Key Industry Developments – Mergers, Acquisitions, and Partnerships
- Global Injectable Cytotoxic Drugs Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- Alkylating Drugs
- Cytotoxic Antibodies
- Antimetabolites
- Plant Alkaloids
- Others
- Market Analysis, Insights and Forecast – By Application
- Oncology
- Multiple Sclerosis
- Rheumatoid Arthritis
- Others
- Market Analysis, Insights and Forecast – By End User
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Injectable Cytotoxic Drugs Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- Alkylating Drugs
- Cytotoxic Antibodies
- Antimetabolites
- Plant Alkaloids
- Others
Report Focus:
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Injectable Cytotoxic Drugs Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report updates
More Trending Topics from Fortune Business Insights:
Wearable Medical Devices Market Worth USD 195.57 Billion by 2027 at an Astounding 26.4% CAGR by 2027
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245